Reactive oligodendrocyte progenitor cells (re-)myelinate the regenerating zebrafish spinal cord.


Journal

Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744

Informations de publication

Date de publication:
16 12 2020
Historique:
received: 14 06 2020
accepted: 28 10 2020
pubmed: 8 11 2020
medline: 29 1 2021
entrez: 7 11 2020
Statut: epublish

Résumé

Spinal cord injury (SCI) results in loss of neurons, oligodendrocytes and myelin sheaths, all of which are not efficiently restored. The scarcity of oligodendrocytes in the lesion site impairs re-myelination of spared fibres, which leaves axons denuded, impedes signal transduction and contributes to permanent functional deficits. In contrast to mammals, zebrafish can functionally regenerate the spinal cord. Yet, little is known about oligodendroglial lineage biology and re-myelination capacity after SCI in a regeneration-permissive context. Here, we report that, in adult zebrafish, SCI results in axonal, oligodendrocyte and myelin sheath loss. We find that OPCs, the oligodendrocyte progenitor cells, survive the injury, enter a reactive state, proliferate and differentiate into oligodendrocytes. Concomitantly, the oligodendrocyte population is re-established to pre-injury levels within 2 weeks. Transcriptional profiling revealed that reactive OPCs upregulate the expression of several myelination-related genes. Interestingly, global reduction of axonal tracts and partial re-myelination, relative to pre-injury levels, persist at later stages of regeneration, yet are sufficient for functional recovery. Taken together, these findings imply that, in the zebrafish spinal cord, OPCs replace lost oligodendrocytes and, thus, re-establish myelination during regeneration.

Identifiants

pubmed: 33158923
pii: 226065
doi: 10.1242/dev.193946
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Auteurs

Vasiliki Tsata (V)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.

Volker Kroehne (V)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.

Daniel Wehner (D)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.
Max Planck Institute for the Science of Light, Erlangen 91058, Germany.
Max-Planck-Zentrum für Physik und Medizin, Erlangen 91058, Germany.

Fabian Rost (F)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.
Center for Information Services and High Performance Computing, TU Dresden, Dresden 01062, Germany.

Christian Lange (C)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.

Cornelia Hoppe (C)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.

Thomas Kurth (T)

Center for Molecular and Cellular Bioengineering (CMCB), TU Dresden, Technology Platform, Dresden 01307, Germany.

Susanne Reinhardt (S)

Dresden Genome Center c/o Center for Regenerative Therapies TU Dresden (CRTD), TU Dresden, Dresden 01307, Germany.

Andreas Petzold (A)

Dresden Genome Center c/o Center for Regenerative Therapies TU Dresden (CRTD), TU Dresden, Dresden 01307, Germany.

Andreas Dahl (A)

Dresden Genome Center c/o Center for Regenerative Therapies TU Dresden (CRTD), TU Dresden, Dresden 01307, Germany.

Markus Loeffler (M)

Center for Advancing Electronics Dresden (cfaed)/Dresden Center for Nanoanalysis (DCN), TU Dresden, Dresden 01062, Germany.

Michell M Reimer (MM)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.

Michael Brand (M)

Center for Regenerative Therapies Dresden TU Dresden (CRTD) and Cluster of Excellence, Physics of Life (PoL), TU Dresden, Dresden 01307, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH